Skip to main content

Table 2 Treatment parameters stratified by positive or negative COVID-19 status (n = number of treatments)

From: Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patients

Treatment Parameters

Total

Non-COVID-19

COVID-19

(n = 87)

(n = 74)

(n = 13)

Blood Flow Rate (mL/min)

  < 150

8% (7)

9% (7)

-

 150 – 200

87% (76)

85% (63)

100% (13)

  > 200

5% (4)

5% (4)

-

Dialysate Flow Rate (mL/min)

  < 100

37% (32)

27% (20)

92% (12)

 100 – 150

53% (46)

65% (44)

-

  > 150

10% (9)

6% (4)

8% (1)

Cartridge Usage

 1 Cartridge

79% (69)

81% (60)

69% (9)

 2 Cartridges

13% (11)

11% (8)

23% (3)

 3 Cartridges

8% (7)

8% (6)

8% (1)

Heparin Drip Used

46% (40)

45% (33)

54% (7)